Overview
Efficacy of Intrathecal Administration of Liposomal Amphotericin B in Cryptococcal Meningitis
Status:
Unknown status
Unknown status
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
The main purpose of this study is to observe the clinical effect of intrathecal administration of liposomal amphotericin B in Cryptococcal Meningitis without Acquired Immune Deficiency Syndrome (AIDS).Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Hui BuTreatments:
Amphotericin B
Liposomal amphotericin B
Criteria
Inclusion Criteria:- Cryptococcus neoformans are found in CSF
Exclusion Criteria:
- Patients with serious heart, lung, liver and renal insufficiency.
- Patients who took broad-spectrum antibiotics and corticosteroids for a long-term.
- Patients with AIDS or obvious immunodeficiency.
- Patients with long term dialysis or intravenous catheter.
- Patients with other brain organic disease such as purulent meningitis, intracranial
swelling, etc.